Genepharm S.A.

Genepharm, a privately held pharmaceutical company, since 1971, has been committed to the development, manufacturing, and distribution of a premium range of generic pharmaceutical products. Genepharm initially focused on the Greek Market, where direct sales were made under its own brand. The company has expanded and now sells its products across Europe, the Middle East, Africa, Asia and the Americas. In 2019 MS Pharma, a fast growing pharmaceutical company based in Jordan acquired Genepharm. In 2021, GENEPHARM was acquired by GMS Holdings.